The Austin, Texas-based neurotech company designed Phantom X as a minimally invasive neural interface that provides intuitive control of prosthetics and robotic devices. The FDA breakthrough designation and TAP designation allow the company to facilitate early and strategic communication with the FDA to help speed up the pathway to commercialization.

Phantom X is implanted just beneath the skin in an outpatient procedure that is accessible by over 70,000 qualified surgeons, according to Phantom Neuro. The platform uses algorithms to decode natural human movement and provide a near-human experience when controlling prosthetic limbs and assistive technologies.